Results 251 to 260 of about 385,548 (309)
Curcumin and Cancer-Related Inflammation. [PDF]
NutrientsLeBlanc K, Brewer E, Aggarwal S.
europepmc +1 more source
Emerging encapsulation techniques for controlled and targeted delivery of bioactive compounds in food and nutraceutical systems. [PDF]
Front NutrKumari K, Tripathy S, Srivastav PP.
europepmc +1 more source
Advanced Propolis Delivery: Strategies for Improved Bioavailability and Therapeutic Efficacy. [PDF]
ACS OmegaKaspute G +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 1971
A variable or poor response to a therapeutic agent may not have its origin in the patient; it may be due to a formulation defect in the drug product administered. The most commonly recognized formulation defect in a dosage form such as a tablet is a deficiency or excess of the active ingredient.
T G, Vitti, D, Banes, T E, Byers
openaire +2 more sources
A variable or poor response to a therapeutic agent may not have its origin in the patient; it may be due to a formulation defect in the drug product administered. The most commonly recognized formulation defect in a dosage form such as a tablet is a deficiency or excess of the active ingredient.
T G, Vitti, D, Banes, T E, Byers
openaire +2 more sources
European Journal of Clinical Pharmacology, 1976
Bioavailability of capsule and tablet formulations of tolamolol were compared by measuring plasma concentration of tolamolol and reduction in maximum exercise heart rate over a period of twelve hours in eight healthy subjects in a two-way cross-over study.
J K, Faulkner +4 more
openaire +2 more sources
Bioavailability of capsule and tablet formulations of tolamolol were compared by measuring plasma concentration of tolamolol and reduction in maximum exercise heart rate over a period of twelve hours in eight healthy subjects in a two-way cross-over study.
J K, Faulkner +4 more
openaire +2 more sources
The bioavailability of phenytoin
Journal of Neurology, 1977The bioavailability of three commercial products of phenytoin (Epanutin, sodium salt; Phenhydan, calcium salt; Zentropil, free acid) was studied relative to a standard solution of sodium phenytoin. Each preparation was given for 14 days in a daily dose of 300 mg according to a cross over design.
R, Gugler +3 more
openaire +2 more sources